U.S. Women Health Laboratory Testing Market to Witness Significant Growth by 2030 | F. Hoffmann-La Roche Ltd, Myriad Genetics, Inc., DiaSorin S.p.A, Natera, Inc.

According to VynZ Research's latest report, titled "U.S. Women Health Laboratory Testing Market - Analysis and Forecast (2025-2030)", the U.S. Women Health Laboratory Testing Market size reached USD 70.2 billion in 2023. It is expected to reach USD 110.5 billion by 2030, exhibiting a CAGR of 4.5% during 2025-2030.

In the United States, the women's health laboratory testing market refers to the business of testing female samples in labs for diseases like ovarian cancer, breast cancer, birth control, gynecological disorders, and sexually transmitted infections (STDs) like chlamydia. Rising awareness of women's health-related tests, average maternal age, which increases the risk of fetal chromosomal aneuploidies, and an increase in reproductive health issues are the factors contributing to the higher demand for laboratory testing among women.

Request Free Sample Report: https://www.vynzresearch.com/healthcare/us-women-health-laboratory-testing-market/request-sample

U.S. Women Health Laboratory Testing Market Trends/Growth :

Additionally, there is a growth in issues related to reproductive health, which raises the demand for laboratory testing among women in the market.

The number of elderly women in the population, the rise in healthcare spending, the prevalence of lifestyle diseases among women, the established healthcare sector, the rise in the demand for fertility tests among women, the expansion of private diagnostic and imaging facilities, the number of women entering the workforce, and the expansion of public-private partnerships will all contribute to the improvement of infrastructure, which will support the industry's growth.

U.S. Women Health Laboratory Testing Market 2025-2030 Competitive Analysis and Segmentation:

Competitive Landscape with Key Players:

The competitive landscape of the U.S. Women Health Laboratory Testing Market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

• F. Hoffmann-La Roche Ltd
• Myriad Genetics, Inc.
• DiaSorin S.p.A
• Natera, Inc.
• Becton
• Dickinson and Company
• Hologic, Inc.
• Quest Diagnostics Incorporated, Abbott
• Cardinal Health
• GE HealthCare

Key Market Segmentation:

The report has segmented the U.S. Women Health Laboratory Testing Market on the basis of type, by Indication, by Distribution Channel and region.

Breakup By Cancer

• Cervical Cancer
• Breast Cancer
• Ovarian Cancer

Breakup By Prenatal Screening and Diagnostic Testing

• Non-Invasive Prenatal Testing (NIPT)
• Maternal Serum Screening (MSS)
• Prenatal Diagnostic Testing

Breakup By Reproductive Health and Infectious Diseases

• Pregnancy and Ovulation Testing
• HPV Testing
• PAP Smear Testing
• HIV Testing
• CT/NG Testing
• Preimplantation Genetic Testing (PGT)
• Sexually Transmitted Infections
• Herpes Simplex Virus (HSV)
• Hepatitis
• Vaginal Infections

Explore Full Report with TOC & List of Figure: https://www.vynzresearch.com/healthcare/us-women-health-laboratory-testing-market

Key Highlights of the Report:

• Market Performance (2018-2023)
• Base Year 2024
• Market Outlook (2025-2030)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About VynZ Research

VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. VynZ has a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies.

Contact US:

Call: +91-996-028-8381
Toll-Free (U.S. and Canada): +1-888-253-3960
Email: kundan@vynzresearch.com
Web: https://www.vynzresearch.com
Visit On Social Media: Facebook | Twitter | Linkedin

This release was published on openPR.